Highlight
Summary
About the Role
About You
- Bachelor's degree and 10 years of experience, or Master's degree and 8 years of experience, or PhD/PharmD and 2 years of experience.
- Advanced knowledge of biomedical statistical analysis and biostatistics best practices.
- 2+ years of experience in autoimmune and/or oncology therapeutic areas.
- Demonstrated ability to be flexible and adaptable to change.
- Strong communication and organizational skills.
- 2+ years’ cross-functional project management or leadership experience in biostatistics or a related field.
Benefits
- Competitive salary range of $153k–$219k based on location and experience.
- Discretionary annual bonus and stock-based long-term incentives.
- Comprehensive benefits package including medical, dental, vision, and life insurance.
At Kite, a Gilead Company, our singular focus is achieving cures with cell therapy. Our goal is to bring the promise of cell therapy to as many eligible patients as possible who may benefit. Since 2009, Kite has been at the forefront of cancer immunotherapy. Today, we are proud to be the leader in engineered T cell therapy for hematologic malignancies, but we recognize that this is just the beginning. Patients are at the heart of our focus on the cure, which is why we are committed to pursuing cell therapy as a transformative treatment option for as many patients as possible who may benefit. Unlike traditional pharmaceutical manufacturing, our therapies are not created on an assembly line. Cell therapy specialists at our manufacturing facilities reengineer a patient’s own immune cells to attack and fight their cancer cells — one patient at a time. That sense of connection to the people we serve motivates us daily at Kite. Our corporate headquarters are located in Santa Monica, California, and we have dedicated cell therapy manufacturing facilities in California, Maryland and the Netherlands. If you’re passionate about bringing the curative potential of cell therapy to more eligible patients, let’s talk. See our community guidelines: http://bit.ly/2DznMNw